Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market - Industry Trends and Forecast to 2027

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market - Industry Trends and Forecast to 2027

Short Description
Asia-Pacific persistent corneal epithelial defects treatment market By Clinical Causes (Inflammatory Disease, Neurotrophic Keratitis (NK), Epithelial/Limbal Stem Cell Deficiency, Others), Type (Devices, Medication), End User (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines, Rest of Asia-Pacific).
Market Definition:
A persistent corneal epithelial defect is a multifactorial condition of the cornea that results from the failure of mechanism of the corneal epithelialization which leads to the disruption in the corneal surface and exposed the eyes vulnerable to the herpetic infections, stromal ulceration and scarring. These defects may persist for several days or even months and it is generally characterized by decreased corneal sensitivity and poor corneal healing. It is manifested by many chronic conditions of the eyes such as limbal cell deficiency, ocular inflammatory disorders, neurotrophic keratitis, herpes simplex and many others.
In healthy eyes, corneal epithelialization plays a crucial role in wound healing and corneal metabolism and thus maintains the cornea’s functionality and integrity. Injury to the corneal surface requires complex corneal epithelialization procedure which involves limbal stem cells acting as, proliferation, cell differentiation and regenerating of the extracellular matrix.
Market Segmentation:
Asia-Pacific persistent corneal epithelial defects treatment market is categorized into five notable segments which are based on the basis of clinical causes, type, end user and distribution channel.

• On the basis of clinical causes, the market is segmented into epithelial/limbal stem cell deficiency, inflammatory disease, neurotrophic keratitis (NK) and others
• On the basis of type, the market is segmented into devices and medication.
• On the basis of end user, the market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

Market Players

The key market players for Asia-Pacific persistent corneal epithelial defects treatment market are listed below:

• Dompé Farmaceutici S.p.A
• Novartis AG
• Allergan
• Next Biosciences
• Katena Products. Inc.
• Johnson & Johnson Services, Inc.
• Hunt Valley PharmaLAB
• Laboratoires THEA S.A.S
• Skye Biologics Inc.
• I-MED Pharma inc.
• Almirall, S.A
• Ocular Science, Inc.
• Kala Pharmaceuticals
• Bausch Health
• Integra LifeSciences Corporation
• BioTissue (A Subsidiary of TissueTech, Inc.)

The single user license is non-downloadable and non-printable. Global Site license allows these actions.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia Pacific Persistent Corneal Epithelial Defects Treatment Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Products Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Market Overview
4.1 Drivers
4.1.1 Increasing Prevalence Of Persistent Corneal Epithelial Defects And Other Related Complications
4.1.2 Rising Cases Of Eye Surgeries And Usage Of Contact Lenses
4.1.3 Growing Ageing Population Augmenting Towards The Pced Condition
4.1.4 Increase In Mechanical Traumas Cases
4.2 Restraint
4.2.1 Stringent Regulatory Procedures
4.2.2 Unmet Medical Needs For The Treatment Of Pced
4.2.3 High Cost Of Persistent Corneal Epithelial Defects Treatments
4.3 Opportunities
4.3.1 Development Of Novel Therapeutics
4.3.2 Increasing Awareness About Diagnosis And Treatment Of The Disease
4.3.3 Strategic Initiatives By Market Players
4.3.4 Emerging Market Economy Creates Significant Opportunities
4.4 Challenges
4.4.1 Dependency On Third Party Suppliers
5 Premium Insights
6 Epidemiology
7 Asia Pacific Persistent Corneal Epithelial Defects Treatment Market, By Clinical Causes
7.1 Overview
7.2 Inflammatory Disease
7.3 Neurotrophic Keratitis (Nk)
7.4 Epithelial/Limbal Stem Cell Deficiency
7.5 Others
8 Asia Pacific Persistent Corneal Epithelial Defects Treatment Market, By Type
8.1 Overview
8.2 Devices
8.2.1 Bandage Contact Lens
8.2.2 Amniotic Membrane Grafts
8.2.3 Punctal Plugs
8.2.3.1 Silicone Plug
8.2.3.2 Collagen Plugs
8.2.4 Corneal Transplants
8.2.4.1 Keratoplasty
8.2.4.2 Keratoprosthesis
8.3 Medication
8.3.1 Drug Type
8.3.1.1 Lubricants
8.3.1.2 Prophylactic Topical Antibiotics
8.3.1.2.1 Polymixin B–trimethoprim + Fluoroquinolone
8.3.1.2.2 Fluoroquinolone
8.3.1.3 Topical Ophthalmic Steroids
8.3.1.4 Autologous Serum Tears/Autologous Serum Eye Drops
8.3.1.5 Tetracyclines
8.3.1.6 Human Nerve Growth Factor (Oxervate)
8.3.1.7 Wound Healing Agents
8.3.1.8 Others
8.3.2 Route Of Administration
8.3.2.1 Topical
8.3.2.2 Oral
9 Asia Pacific Persistent Corneal Epithelial Defects Treatment Market, By End User
9.1 Overview
9.2 Hospitals
9.3 Homecare
9.4 Specialty Clinics
9.5 Others
10 Asia Pacific Persistent Corneal Epithelial Defects Treatment Market, By Distribution Channel
10.1 Overview
10.2 Hospital Pharmacies
10.3 Retail Pharmacies
10.4 Online Pharmacies
11 Asia Pacific Persistent Corneal Epithelial Defects Treatment Market, By Geography
11.1 Asia-pacific
11.1.1 Japan
11.1.2 China
11.1.3 India
11.1.4 South Korea
11.1.5 Australia
11.1.6 Singapore
11.1.7 Thailand
11.1.8 Malaysia
11.1.9 Indonesia
11.1.10 Philippines
11.1.11 Vietnam
11.1.12 Rest Of Asia-pacific
12 Asia Pacific Persistent Corneal Epithelial Defects Treatment Market, Company Landscape
12.1 Company Share Analysis: Asia-pacific
13 Company Profile
13.1 Johnson & Johnson Services, Inc.
13.1.1 Company Snapshot
13.1.2 Revenue Analysis
13.1.3 Company Share Analysis
13.1.4 Product Portfolio
13.1.5 Recent Developments
13.2 Allergan
13.2.1 Company Snapshot
13.2.2 Revenue Analysis
13.2.3 Company Share Analysis
13.2.4 Product Portfolio
13.2.5 Recent Development
13.3 Bio-tissue (A Subsidiary Of Tissuetech, Inc.)
13.3.1 Company Snapshot
13.3.2 Company Share Analysis
13.3.3 Product Portfolio
13.3.4 Recent Developments
13.4 Laboratoires Théa S.A.S
13.4.1 Company Snapshot
13.4.2 Company Share Analysis
13.4.3 Product Portfolio
13.4.4 Recent Development
13.5 Novartis Ag
13.5.1 Company Snapshot
13.5.2 Revenue Analysis
13.5.3 Product Portfolio
13.5.4 Recent Development
13.6 Bausch Health
13.6.1 Company Snapshot
13.6.2 Revenue Analysis
13.6.3 Product Portfolio
13.6.4 Recent Development
13.7 Integra Lifesciences Corporation
13.7.1 Company Snapshot
13.7.2 Revenue Analysis
13.7.3 Product Portfolio
13.7.4 Recent Development
13.8 Almirall, S.A
13.8.1 Company Snapshot
13.8.2 Revenue Analysis
13.8.3 Product Portfolio
13.8.4 Recent Development
13.9 Dompé Farmaceutici S.P.A.
13.9.1 Company Snapshot
13.9.2 Product Portfolio
13.9.3 Recent Developments
13.10 Hunt Valley Pharmalab
13.10.1 Company Snapshot
13.10.2 Product Portfolio
13.10.3 Recent Development
13.11 I-med Pharma Inc.
13.11.1 Company Snapshot
13.11.2 Product Portfolio
13.11.3 Recent Development
13.12 Kala Pharmaceuticals
13.12.1 Company Snapshot
13.12.2 Product Portfolio
13.12.3 Recent Developments
13.13 Katena Products. Inc.
13.13.1 Company Snapshot
13.13.2 Product Portfolio
13.13.3 Recent Developments
13.14 Next Biosciences
13.14.1 Company Snapshot
13.14.2 Product Portfolio
13.14.3 Recent Development
13.15 Ocular Science, Inc.
13.15.1 Company Snapshot
13.15.2 Product Portfolio
13.15.3 Recent Development
13.16 Skye Biologics Inc.
13.16.1 Company Snapshot
13.16.2 Product Portfolio
13.16.3 Recent Development
14 Questionnaire
15 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook